Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer. - Yang JC; Lee DH; Lee JS; Fan Y; de Marinis F; Iwama E; Inoue T; Rodríguez-Cid J; Zhang L; Yang CT; de la Mora Jimenez E; Zhou J; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024)